B3B

Home/B3B

About B3B

This author has not yet filled in any details.
So far B3B has created 188 blog entries.

Skaggs Family Donates $2 Million to Scripps Research

From press release: "The Skaggs family has given a new $2 million gift to support exceptional students in The Scripps Research Institute (TSRI) graduate program. "I would like to thank members of the Skaggs family for their remarkable generosity, which has had a transformative effect on this institution," said TSRI CEO Peter Schultz. "This new [...]

June 2nd, 2016|

Biocept Demonstrates the Solid Future of Liquid Biopsies

A recent mendelspod podcast profiles Biocept, its CEO and future of liquid biopsies - an overview and an excerpt: Michael Nall, CEO of Biocept Chapters: 0:00 A $20 billion market 4:09 How many tests have you sold to date? 6:36 At what point will the liquid biopsy be preferred to solid tumor biopsy? 11:07 [...]

May 21st, 2016|

Upcoming Event Spotlight: America’s Antibody Congress, May 19-20

Antibody based drugs are having a profound impact on the pharmaceutical industry. From an approved bispecific treatment and more on the way to infectious diseases and immunotherapy, antibodies are proving their worth in the clinic and in the patient. So why does it seem people have nothing new to talk about at events? America’s Antibody [...]

May 9th, 2016|

Upcoming Event Spotlight: World Biosimilar Congress, May 19-20

Following the release of the FDA’s purple book, the World Biosimilar Congress (WBC) USA launched in 2015 to bring focus to the important and distinct issues facing the biopharmaceutical industry. When it comes to developing and commercializing biosimilars in the United States from the payer or biosimilar manufacturing perspective, WBC is the largest event in [...]

May 9th, 2016|

How Craig Venter Is Fighting Aging With Genome Sequencing

Intro to feature article in WIRED: "Nine years ago, Craig Venter sequenced the first complete individual human genome - his own. Now, he's finally starting to decode what it means for his future. In early 2006, Craig Venter received a worrying email concerning his genome. Amid the six billion letters-long sequence of the A, T, [...]

May 4th, 2016|

SBP and GSK Create New Center for Translational Neuroscience

Coverage of the new center from Sanford Burnham Prebys and GlaxoSmithKline designed to "advance translational neuroscience by identifying and validating new therapeutic targets": GSK, Sanford Burnham Prebys Create Translational Neuroscience Center (GEN) "The new SBP-GSK Center for Translational Neuroscience—to be located on SBP’s campus in La Jolla, CA—will promote collaboration by researchers from SBP and GSK. SBP scientists, [...]

April 20th, 2016|
X